Matthew DelMauro, MD Observes Rise in Plastic Surgery at his NYC Practice Following GLP-1-Related Weight Loss
NEW YORK, Jan. 21, 2026 /PRNewswire/ — Matthew DelMauro, MD, board-certified plastic surgeon, is reporting a noticeable increase in patients seeking plastic surgery after significant weight loss associated with GLP-1 medications. While these medications have helped many individuals…
Ozempic just released its own version of the iconic Mac vs. PC ad
Novo Nordisk’s ‘There’s Only One Ozempic’ campaign is about reasserting the drugmaker’s brand name in an increasingly competitive landscape. Ozempic-maker Novo Nordisk turned to the actors from Apple’s 2000s “Get a Mac” ads to differentiate its GLP-1 medication amid a rising sea of competitors.
Ozempic Improves Knee Replacement Outcomes Among People With Type 2 Diabetes
WEDNESDAY, Jan. 21, 2026 — Even a brief round of Ozempic can help people with type 2 diabetes have a more successful knee replacement surgery, a new study says.
Patients given Ozempic just a few months prior to their knee replacement surgery…
Topical Volumizing Cream Improves Facial Volume and Skin Health in Adults With Rapid Weight Loss From Pharmacologic (GLP‐1/GIP Agonists), Surgical, or Behavioral Interventions
ABSTRACT Background GLP-1 receptor agonists (GLP-1) and dual GLP-1/gastric inhibitory polypeptide (GIP) agonists emerged in recent years to promote weight loss. By reducing subcutaneous fat, collagen, and overall structural support of the skin, rapid weight loss can lead to visual face aging. Aims This study investigates the synergistic effect of a multi-ingredient topical that acts […]
Managing Aesthetic Needs in Prescription Medication‐Driven Rapid Weight Loss Patients: Results of an International Consensus. The Clinician Perspective
ABSTRACT Introduction The global prevalence of obesity has continued to increase at alarming rates. More recently, there has been an exponential increase in the usage of GLP1 agonists in both clinically obese patients and those seeking weight loss. As a result, there has been an influx of patients who are noticing substantial weight loss and […]
The eureka moment that drove Oprah to reframe weight loss and banish shame involved a Post-It
Oprah Winfrey at the American Ballet Theatre Gala on October 22, 2025. Lanna Apisukh/WWD via Getty Images Oprah Winfrey has been a weight-loss icon for decades and has always carried some shame — until now. She recently reframed her own weight loss and now says she’ll be on obesity medication for life. A new book, […]
Ozempic Brings Back The ‘Get A Mac’ Guys As GLP-1 Rivalry Heats Up
Who says pharma can’t have personality? Ozempic leans into humor with a familiar duo, Justin Long and John Hodgman from the ‘Mac VS PC’ era.
Lupin signs licensing pact with Galenicum Health for injectable Semaglutide
Lupin Atlantis Holdings SA (LAHSA) has entered into a partnership with Galenicum for finished formulations of injectable Semaglutide, a GLP-1 receptor agonist
Novo Nordisk Reteams Apple's Long/Hodgman Ad Duo To Tout Ozempic
Justin Long and John Hodgman this time represent, respectively, Novo Nordisk’s original GLP-1, Ozempic, vs. “other GLP-1 products for type 2 diabetes.”
How Employers Can Save $550/Month on GLP-1s: Introducing Vida Self-Pay
What You Should Know – Vida Health has partnered with RxSaveCard to launch Vida Self-Pay, a first-of-its-kind platform that bypasses traditional PBM markups for anti-obesity medications (AOMs). – By combining virtual, whole-person clinical care with transparent “cash-price” subsidies, the partnership enables employers to save up to $550 per member per month while expanding access to […]